Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.! 京ICP备19006400号-1 Powered by 300.cn
美科
Links:
Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA approval of its application for a Phase II clinical trial treating COVID-19 patients with MSCs.
Source:
Release time:
2020/09/27 14:11
Page view
Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA approval of its application for a Phase II clinical trial treating COVID-19 patients with MSCs.